VICP Registry Case Source Bundle
Canonical URL: https://vicp-registry.org/case/USCOURTS-cofc-1_24-vv-00319
Package ID: USCOURTS-cofc-1_24-vv-00319
Petitioner: Joshua T. Greeley
Filed: 2024-02-29
Decided: 2026-01-22
Vaccine: tetanus, diphtheria, and acellular pertussis (Tdap) and human papillomavirus (HPV)
Vaccination date: 2022-05-24
Condition: vasovagal syncope with residual effects
Outcome: compensated
Award amount USD: 37500

AI-assisted case summary:
On February 29, 2024, Joshua T. Greeley filed a petition alleging that Tdap and HPV vaccines administered on May 24, 2022 caused vasovagal syncope with residual effects lasting more than six months.

Respondent denied that the vaccinations caused Mr. Greeley's alleged injury or any other condition. The public stipulation does not describe the immediate syncopal event, emergency care, testing, treatment, or residual symptoms.

The parties settled the case by stipulation. On January 22, 2026, Chief Special Master Brian H. Corcoran adopted the stipulation and awarded $37,500.00 as a lump sum through counsel's IOLTA account for all damages available under the Vaccine Act.

Theory of causation field:
Tdap and HPV vaccines May 24, 2022 allegedly causing vasovagal syncope with residual effects; adult, exact age not stated; same-day onset. COMPENSATED by stipulation. Respondent denied causation; public stipulation lacks clinical chronology. Award $37,500. Chief SM Brian H. Corcoran; petition February 29, 2024; decision January 22, 2026.

Public staged source text:

================================================================================
DOCUMENT 1: USCOURTS-cofc-1_24-vv-00319-0
Date issued/filed: 2026-02-17
Pages: 7
Docket text: PUBLIC DECISION (Originally filed: 1/22/2026) regarding 36 DECISION on Stipulation. Signed by Special Master Mindy Michaels Roth. (nb) Service on parties made.
--------------------------------------------------------------------------------
Case 1:24-vv-00319-UNJ Document 40 Filed 02/17/26 Page 1 of 7
In the United States Court of Federal Claims
OFFICE OF SPECIAL MASTERS
No. 24-319V
Filed: January 22, 2026
* * * * * * * * * * * * *
JOSHUA T. GREELEY, *
*
Petitioner, *
*
*
v. *
*
SECRETARY OF HEALTH *
AND HUMAN SERVICES, *
*
Respondent. *
* * * * * * * * * * * * *
Elizabeth M. Muldowney, Esq., Sands Anderson PC, Richmond, VA, for petitioner.
Mary E. Holmes, Esq., US Department of Justice, Washington, DC, for respondent.
DECISION ON JOINT STIPULATION1
Roth, Special Master:
On February 29, 2024, Joshua T. Greeley filed a petition for compensation under the
National Vaccine Injury Compensation Program.2 Petitioner alleges that he developed a vasovagal
syncope with residual effects lasting longer than six months after receiving Tdap and HPV
vaccines on May 24, 2022. Stipulation, filed January 22, 2026, at ¶¶ 1-4. Respondent denies that
the immunization caused petitioner’s alleged injury. Stipulation at ¶ 6.
Nevertheless, the parties have agreed to settle the case. On January 22, 2026, the parties
filed a joint stipulation agreeing to settle this case and describing the settlement terms.
1 Because this Decision contains a reasoned explanation for the action taken in this case, it must be made publicly
accessible and will be posted on the United States Court of Federal Claims' website, and/or
at https://www.govinfo.gov/app/collection/uscourts/national/cofc, in accordance with the E-Government Act of 2002.
44 U.S.C. § 3501 note (2018) (Federal Management and Promotion of Electronic Government Services). This means
the Decision will be available to anyone with access to the internet. In accordance with Vaccine Rule 18(b),
Petitioner has 14 days to identify and move to redact medical or other information, the disclosure of which would
constitute an unwarranted invasion of privacy. If, upon review, I agree that the identified material fits within this
definition, I will redact such material from public access.
2 National Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660, 100 Stat. 3755. Hereinafter, for ease of citation,
all “§” references to the Vaccine Act will be to the pertinent subparagraph of 42 U.S.C. § 300aa (2018).
1

Case 1:24-vv-00319-UNJ Document 40 Filed 02/17/26 Page 2 of 7
Respondent agrees to issue the following payment:
A lump sum of $37,500.00, to be paid through an ACH deposit to petitioner’s
counsel’s IOLTA account for prompt distribution to petitioner. This amount represents
compensation for all damages that would be available under § 300aa-15(a).
I adopt the parties’ stipulation attached hereto, and award compensation in the amount and
on the terms set forth therein. The clerk of the court is directed to enter judgment in accordance
with this decision.3
IT IS SO ORDERED.
s/ Mindy Michaels Roth
Mindy Michaels Roth
Special Master
3 Pursuant to Vaccine Rule 11(a), entry of judgment can be expedited by each party filing a notice renouncing the
right to seek review.
2

Case 1:24-vv-00319-UNJ Document 40 Filed 02/17/26 Page 3 of 7
IN THE UNITED STATES COURT OF FEDERAL CLAIMS
OFFICE OF SPECIAL MASTERS
JOSHUA T. GREELEY,
Petitioner,
No. 24-319V
v. Special Master Roth
ECF
SECRETARY OF HEALTH AND HUMAN
SERVICES,
Respondent.
STIPULATION
The parties hereby stipulate to the following matters:
1. Joshua T. Greeley (“petitioner”) filed a petition for vaccine compensation under the
National Vaccine Injury Compensation Program, 42 U.S.C. § 300aa-10 to 34 (the “Vaccine
Program”). The petition seeks compensation for injuries allegedly related to petitioner’s receipt
of tetanus, diphtheria, and acellular pertussis (“Tdap”) and/or human papillomavirus (“HPV”)
vaccines, which vaccines are contained in the Vaccine Injury Table (the “Table”), 42 C.F.R.
§100.3(a).
2. Petitioner received Tdap and HPV vaccines on May 24, 2022.
3. The vaccines were administered within the United States.
4. Petitioner alleges that he suffered from a vasovagal syncope within the time period set
forth in the Table following administration of the vaccine. Petitioner further alleges that he
experienced the residual effects of this condition for more than six months.
5. Petitioner represents that there has been no prior award or settlement of a civil action
for damages on petitioner’s behalf because of the alleged injury.

Case 1:24-vv-00319-UNJ Document 40 Filed 02/17/26 Page 4 of 7
6. Respondent denies that petitioner sustained a vasovagal syncope Table injury; denies
that the Tdap and/or HPV vaccines caused petitioner’s alleged vasovagal syncope, or any other
injury; and denies that his current condition is a sequela of a vaccine-related injury.
7. Maintaining their above-stated positions, the parties nevertheless now agree that the
issues between them shall be settled and that a decision should be entered awarding the
compensation described in paragraph 8 of this Stipulation.
8. As soon as practicable after an entry of judgment reflecting a decision consistent with
the terms of this Stipulation, and after petitioner has filed an election to receive compensation
pursuant to 42 U.S.C. § 300aa-21(a)(1), the Secretary of Health and Human Services will issue
the following vaccine compensation payment for all damages that would be available under 42
U.S.C. § 300aa-15(a):
A lump sum of $37,500.00 to be paid through an ACH deposit to petitioner’s
counsel’s IOLTA account for prompt disbursement to petitioner.
9. As soon as practicable after the entry of judgment on entitlement in this case, and after
petitioner has filed both a proper and timely election to receive compensation pursuant to 42
U.S.C. § 300aa-21(a)(1), and an application, the parties will submit to further proceedings before
the special master to award reasonable attorneys’ fees and costs incurred in proceeding upon this
petition.
10. Petitioner and petitioner’s attorney represent that compensation to be provided
pursuant to this Stipulation is not for any items or services for which the Program is not
primarily liable under 42 U.S.C. § 300aa-15(g), to the extent that payment has been made or can
reasonably be expected to be made under any State compensation programs, insurance policies,
Federal or State health benefits programs (other than Title XIX of the Social Security Act (42
U.S.C. § 1396 et seq.)), or by entities that provide health services on a pre-paid basis.
2

Case 1:24-vv-00319-UNJ Document 40 Filed 02/17/26 Page 5 of 7
Payment made pursuant to paragraph 8 and any amounts awarded pursuant to
paragraph 9 of this Stipulation will be made in accordance with 42 U.S.C. § 300aa-15(i), subject
to the availability of sufficient statutory funds.
12. The parties and their attorneys further agree and stipulate that, except for any award
for attorneys’ fees and litigation costs, and past unreimbursed expenses, the money provided
pursuant to this Stipulation will be used solely for the benefit of petitioner as contemplated by a
strict construction of 42 U.S.C. § 300aa-15(a) and (d), and subject to the conditions of 42 U.S.C.
§300aa-15(g) and (h).
13. In return for the payments described in paragraphs 8 and 9, petitioner, in petitioner’s
individual capacity, and on behalf of petitioner’s heirs, executors, administrators, successors or
assigns, does forever irrevocably and unconditionally release, acquit and discharge the United
States and the Secretary of Health and Human Services from any and all actions or causes of
action (including agreements, judgments, claims, damages, loss of services, expenses and all
demands of whatever kind or nature) that have been brought, could have been brought, or could
be timely brought in the Court of Federal Claims, under the National Vaccine Injury
Compensation Program, 42 U.S.C. § 300aa-10 et seq., on account of, or in any way growing out
of, any and all known or unknown, suspected or unsuspected personal injuries to or death of
petitioner resulting from, or alleged to have resulted from, the Tdap and/or HPV vaccinations
administered on May 24, 2022, as alleged in a petition for vaccine compensation filed on or
about February 29, 2024, in the United States Court of Federal Claims as petition No. 24-319V.
14. If petitioner should die prior to entry of judgment, this agreement shall be voidable
upon proper notice to the Court on behalf of either or both of the parties.
3

Case 1:24-vv-00319-UNJ Document 40 Filed 02/17/26 Page 6 of 7
15. If the special master fails to issue a decision in complete conformity with the terms
of this Stipulation or if the Court of Federal Claims fails to enter judgment in conformity with a
decision that is in complete conformity with the terms of this Stipulation, then the parties’
settlement and this Stipulation shall be voidable at the sole discretion of either party.
16. This Stipulation expresses a full and complete negotiated settlement of liability and
damages claimed under the National Childhood Vaccine Injury Act of 1986, as amended, except
as otherwise noted in paragraph 9 above. There is absolutely no agreement on the part of the
parties hereto to make any payment or to do any act or thing other than is herein expressly stated
and clearly agreed to. The parties further agree and understand that the award described in this
Stipulation may reflect a compromise of the parties’ respective positions as to liability and/or
amount of damages, and further, that a change in the nature of the injury or condition or in the
items of compensation sought, is not grounds to modify or revise this agreement.
17. This Stipulation shall not be construed as an admission by the United States or the
Secretary of Health and Human Services that the Tdap and/or HPV vaccines caused petitioner’s
alleged injury or any other injury or petitioner’s current disabilities, or that petitioner suffered an
injury contained in the Vaccine Injury Table.
18. All rights and obligations of petitioner hereunder shall apply equally to petitioner’s
heirs, executors, administrators, successors, and/or assigns.
END OF STIPULATION
/
/
/
4

Case 1:24-vv-00319-UNJ Document 40 Filed 02/17/26 Page 7 of 7